Ads
related to: hsoc adjuvant radiation procedure for prostate cancer surgery survival rate- About Us
Understand how a PSMA PET scan may
help with your treatment plan.
- Talk To Your Doctor
Review questions to start a
conversation with your doctor.
- Reimbursement Support
The patient support program
can assist insurance assessment.
- Find An Imaging Site
Locate the nearest imaging site
or contact customer service.
- About Us
everydayhealth.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Radiation therapy is commonly used in prostate cancer treatment. It may be used instead of surgery or after surgery in early-stage prostate cancer (adjuvant radiotherapy). Radiation treatments also can be combined with hormonal therapy for intermediate risk disease, when surgery or radiation therapy alone is less likely to cure the cancer.
Brachytherapy is a type of radiotherapy, or radiation treatment, offered to certain cancer patients. There are two types of brachytherapy – high dose-rate (HDR) and low dose-rate (LDR). LDR brachytherapy is the one most commonly used to treat prostate cancer. It may be referred to as 'seed implantation' or it may be called 'pinhole surgery'. [1]
Adjuvant pelvic radiation therapy has received scrutiny for its use in women under 60, as studies have indicated decreased survival and increased risk of second malignancies following treatment. [36] In advanced-stage endometrial cancer, adjuvant therapy is typically radiation, chemotherapy, or a combination of the two.
For prostate cancer, the best treatment often depends on the risk level presented by the disease. For most prostate cancers classified as "very low risk" and "low risk", radical prostatectomy is one of several treatment options; others include radiation, watchful waiting, and active surveillance.
Body sites in which brachytherapy can be used to treat cancer. Brachytherapy is commonly used to treat cancers of the cervix, prostate, breast, and skin. [1]Brachytherapy can also be used in the treatment of tumours of the brain, eye, head and neck region (lip, floor of mouth, tongue, nasopharynx and oropharynx), [10] respiratory tract (trachea and bronchi), digestive tract (oesophagus, gall ...
The rate of death from prostate cancer at 10 years for men age 65–74 years with moderately differentiated cancers (Gleason score 5–7) diagnosed with screening (in the prostate cancer screening era) and pre prostate cancer screening eras (without screening) were from 2-6%, and from 15 to 23%, respectively.
Ads
related to: hsoc adjuvant radiation procedure for prostate cancer surgery survival rateeverydayhealth.com has been visited by 10K+ users in the past month